Related Experiment Video
Updated: Jul 2, 2026
09:45
An Oligonucleotide-based Tandem RNA Isolation Procedure to Recover Eukaryotic mRNA-Protein Complexes
Published on: August 18, 2018
Antibody-oligonucleotide conjugates: an emerging modality for precision RNA therapeutics
Chen-Hsu Yu1, Summer Y Y Ha2, Zhiqiang An2
1Department of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, United States.
Antibody Therapeutics
|July 1, 2026
Summary
Antibody-oligonucleotide conjugates (AOCs) deliver RNA therapeutics to specific cells. This approach overcomes delivery limitations, offering new treatments for previously untreatable diseases.
Area of Science:
- Biotechnology
- Molecular Biology
- Drug Discovery
Background:
- RNA-targeting therapeutics offer precise disease intervention.
- Current RNA drugs face challenges in reaching target tissues or cells.
- Antibody-oligonucleotide conjugates (AOCs) are emerging as a solution for targeted delivery.
Purpose of the Study:
- To review the components, design, and manufacturing of AOCs.
- To summarize current preclinical and clinical AOC development and disease applications.
- To discuss challenges and future opportunities for AOCs in RNA therapeutics.
Main Methods:
- Review of existing literature on antibody-oligonucleotide conjugates.
- Analysis of AOC components, design principles, and manufacturing considerations.
- Evaluation of preclinical and clinical data for AOCs in various disease indications.
Main Results:
- AOCs effectively utilize antibodies for targeted delivery of RNA-targeting payloads.
- Key design and manufacturing considerations are crucial for AOC efficacy.
- Ongoing AOCs show promise across diverse preclinical and clinical studies.
Conclusions:
- AOCs represent a significant advancement in RNA therapeutics, overcoming traditional delivery barriers.
- Addressing current challenges in AOC efficacy and application will unlock their full potential.
- AOCs offer unique opportunities beyond conventional RNA drugs and antibody-drug conjugates, potentially revolutionizing treatment for intractable diseases.
Related Concept Videos
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
03:21RNA-seq
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...